Guidelines and Standards

Australian

• National Health and Medical Research Council (NHMRC)
  • Clinical Practice Guidelines for the use of blood Components
    This link enables users to read and download PDF publications, that provide information on the clinical practice guidelines for the use of blood components.
    
    
• Australian Health Minister Advisory Council (AHMAC) FVIII & FIX guidelines (2006) (1.3MB)
  These evidence-based clinical guidelines detail treatment regimens and alternatives for people with haemophilia A and B, and von Willebrand disease. These guidelines are intended to inform clinicians and people with haemophilia of the safest and most effective strategies using the best available evidence.
  
  In addition to reflecting recent changes to national policy and the availability of recombinant factors, they provide detailed guidance on the selection and use of appropriate products for prophylaxis, treatment of acute bleeding episodes, surgical and dental procedures, antenatal care and delivery of infants. They also provide strategies for using adjunctive agents, managing inhibitors, and address the lack of consensus surrounding tolerization protocols.

• Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg) in Australia – Effective 3 March 2008
  

  The Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg) in Australia has been developed to assist clinicians and transfusion medicine professionals to identify the conditions and circumstances for which the use of intravenous immunoglobulin (IVIg) is appropriate.
  
  

• Australian and New Zealand Society of Blood Transfusion (ANZSBT)
  This link allows access to publications on transfusion medicine and guidelines from Australia and New Zealand.  It also includes information for meetings in Australia, New Zealand and internationally.
  
  
• Australian Council on Healthcare Standards. EQUIP4.
  This link allows access to EQUIP4 standards. These standards for patient safety in Australia are produced by the Australian Council on Healthcare Standards.
  
  
• Guidelines on the prophylactic use of Rh D immunoglobulin (anti-D) in obstetrics - June 2003 (850KB)
  This document, produced by the National Blood Authority and approved by the National Health and Medical Research Council, updates previous guidelines on the use of Rh D immunoglobulin (anti-D) released in 1999. It aims to inform clinicians, other health professionals and policy makers about the revised recommendations for use of anti-D in Australia.
  
  Since the release of this document, the National Blood Authority has announced Stage 2 in a three-stage program, which extends routine antenatal prophylaxis to all Rh (D) negative women without preformed antibodies.
  
  Further information on the use of anti-D during pregnancy is available from the Australian Red Cross Blood Service.

International

• British Committee for Standards in Haematology (BH)
  This web site provides access to BH guidelines and information on work in progress. A facility to register for email alerts to final drafts of guidelines is also provided.
  
  
• UK Blood Service
  This site provides information on safe and appropriate use of blood including clinical guidelines, clinical audits and publications.

Agreement Ensures Continuation of Blood Plasma Supplies

Imported IVIg Stakeholder Discussion Paper

Imported IVIg Suppliers Request for Information

Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg)

Employment Opportunities

- APS 3 Corporate Services Support Officer (Part Time)

- APS 4 Executive Support Officer (On-going)

NBA Newsfeed
Subscribe to RSS
-- What is RSS?